Test Price
2,800 AED✅ Home Collection Available
STIM1 Gene Myopathy, Tubular Aggregate, Type 1 Genetic Test in UAE | 2800 AED | DHA Guidelines
Executive Summary & Core Metrics
This definitive DNA sequencing test for STIM1-related tubular aggregate myopathy delivers 99.9% diagnostic sensitivity under ISO 9001:2015 accredited genetic processing (Cert: INT/EGQ/2509DA/3139). Our premium logistics include VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily from 8 AM to 11 PM). Direct insurance billing verification via WhatsApp at +971 54 548 8731. Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning Use of ICT in Health Fields ensure full regulatory compliance.
Test Overview & Methodology
This next‑generation sequencing test analyzes the full coding region of the STIM1 gene to detect pathogenic variants causing tubular aggregate myopathy type 1—a rare congenital neuromuscular disorder. Results guide targeted management, genetic counselling, and reproductive risk assessment.
| Feature | Our Test | Alternative (Single‑Gene Sanger) |
|---|---|---|
| Diagnostic Precision | 99.9% NGS analytical sensitivity | ~95% for known hot‑spots |
| Methodology | Illumina® NovaSeq™ with bioinformatic filtering | Capillary electrophoresis, limited to single variant |
| Turnaround Time | 21 – 28 calendar days | 30 – 45 days |
| Sample Acceptance | Blood, Extracted DNA, or One Drop on FTA Card | Only whole blood |
All methods comply with DHA and MOHAP regulations. Pre‑test genetic counselling is mandatory.
Physician Insight & Safety Protocols
“While a positive STIM1 result provides a clear molecular diagnosis, clinical correlation remains essential—symptoms vary even within families. As your partner in care, I emphasize that every genetic finding must be integrated with a thorough neurological examination, EMG/NCV studies, and biochemical profiling to craft a truly personalized management plan. Please never alter therapy based solely on a lab report; always consult your specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License No. 9294403
Advisory & Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic results do not replace clinical judgment.
Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or recent major surgery (postpone collection).
- Known severe coagulopathy or platelet disorder contraindicating phlebotomy.
- For DNA on FTA card: insufficient drying or contamination.
- Urgent care: If the patient develops acute respiratory distress, cardiac arrhythmia, or malignant hyperthermia‑like symptoms, seek emergency medical attention immediately. Do not wait for test results.
Patient FAQ & Clinical Guidance
1. How accurate is this STIM1 gene test for diagnosing tubular aggregate myopathy in children and adults?
With an analytical sensitivity exceeding 99.9%, this NGS‑based test detects nearly all pathogenic single‑nucleotide variants, small insertions/deletions, and copy‑number changes in the STIM1 gene, providing a definitive molecular diagnosis when clinical suspicion is high. Our ISO‑certified laboratory uses peer‑reviewed bioinformatic pipelines that minimise false‑positive calls.
2. Can this test be performed on children, and is it covered by health insurance in the UAE?
Yes, the test is suitable for all ages, including children, with parental consent. Insurance coverage varies; we offer pre‑approval verification via WhatsApp ( +971 54 548 8731) to ensure you benefit from coverage accepted by the Dubai Health Authority.
3. What sample types are accepted and how should I prepare?
The laboratory accepts a single 5 mL EDTA whole blood tube, extracted DNA (≥ 2 µg), or one dried blood spot on an FTA card—no fasting required. Prior to collection, you must complete a genetic counselling session to map your family pedigree and discuss implications. Avoid heparin‑based anticoagulants; detailed instructions will be provided by our mobile phlebotomy team.
UAE Regulatory & Data Privacy Adherence
Your personal health data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. DNA Labs UAE adheres to strict confidentiality and data security measures. All genetic testing procedures comply with the ethical guidelines and licensing requirements of the Dubai Health Authority (DHA).
Clinical & Logistical Metadata
| Test Name | STIM1 Gene Myopathy, Tubular Aggregate, Type 1 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21 – 28 calendar days |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card |
| Methodology Used | Next-Generation Sequencing (Illumina NovaSeq) with bioinformatic analysis |
| ICD-10-CM Code | G71.03 |
| LOINC Code | 94233-3 |
| DHA Facility License & Laboratory Address | DHA Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians